Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- CANCERS15(5) · 2023
- 피인용
- Web of Science 4Scopus 5
- FWCI (Scopus)
- 0.4
- JCR IF
- JCR 2022 5.2
- ISSN
- 2072-6694
저자
- Kim, Insu제1저자Dong A Univ Hosp, Dept Internal Med, Busan 49201, South Korea
- 설희윤Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan 50612, South Korea
- 김수한Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
- 김미현Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
- 이민기Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
- 엄중섭교신저자Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
초록
Background: Detection of the epidermal growth factor receptor (EGFR) T790M mutation using plasma samples has been considered simple and non-invasive, but the relatively high false negative results lead to additional tissue sampling in some patients. Until now, the characteristics of patients who prefer liquid biopsy have not yet been established. Methods: To evaluate the favorable conditions for the detection of T790M mutations using plasma samples, a multicenter retrospective study was performed between May 2018 and December 2021. Patients whose T790M mutation was detected in a plasma sample were classified as the plasma positive group. Study subjects with a T790M mutation not detected in a plasma sample but only in a tissue sample were grouped as the plasma false negative group. Results: Plasma positive and plasma false negative groups were found in 74 and 32 patients, respectively. As a result, 40% of patients with one or two metastatic organs at the time of re-biopsy had false negative plasma sample results, and 69% of patients with three or more metastatic organs at the time of re-biopsy had positive plasma results. In multivariate analysis, three or more metastatic organs at initial diagnosis were independently associated with the detection of a T790M mutation using plasma samples. Conclusion: Our results demonstrated that the detection rate of a T790M mutation using plasma samples was related to the tumor burden, particularly to the number of metastatic organs.
키워드
diagnostic molecular pathologyepidermal growth factor receptorliquid biopsylung cancertyrosine kinase inhibitorLIQUID-BIOPSYRESISTANCEGUIDELINE
식별자
- Scopus EID
- 2-s2.0-85149806494
- WoS UID
- 000947421400001



로그인
연구물 목록으로